ATF2 was enriched in the TNF signaling pathway, suggesting that miR-16-5p/miR-134-5p targeting circ_ATF2_001418 might act in the mechanisms of NSCLC through the TNF signaling pathway. This evidence concerns the gene ATF2 and non-small cell lung carcinoma.